These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 20067875

  • 1. Proniosomes as drug carriers.
    Sankar V, Ruckmani K, Durga S, Jailani S.
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [Abstract] [Full Text] [Related]

  • 2. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR, Jakki SL, Natarajan J, Kuppusamy G.
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [Abstract] [Full Text] [Related]

  • 3. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM.
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [Abstract] [Full Text] [Related]

  • 4. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M, Sammour OA, Hammad MA, Megrab NA.
    Int J Pharm; 2008 Sep 01; 361(1-2):104-11. PubMed ID: 18577437
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA.
    J Microencapsul; 2009 May 01; 26(3):272-8. PubMed ID: 18720197
    [Abstract] [Full Text] [Related]

  • 6. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D, Garg A, Kaur IP.
    J Pharm Pharmacol; 2004 Dec 01; 56(12):1509-17. PubMed ID: 15563757
    [Abstract] [Full Text] [Related]

  • 7. Proniosomal powder of captopril: formulation and evaluation.
    Gupta A, Prajapati SK, Singh M, Balamurugan M.
    Mol Pharm; 2007 Dec 01; 4(4):596-9. PubMed ID: 17472398
    [Abstract] [Full Text] [Related]

  • 8. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS, Mortada ND, Mansour S, Hathout RM.
    Int J Pharm; 2005 Dec 08; 306(1-2):71-82. PubMed ID: 16263229
    [Abstract] [Full Text] [Related]

  • 9. Technology overview and drug delivery application of proniosome.
    Ahmad MZ, Mohammed AA, Mokhtar Ibrahim M.
    Pharm Dev Technol; 2017 May 08; 22(3):302-311. PubMed ID: 26794727
    [Abstract] [Full Text] [Related]

  • 10. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Abd-Elbary A, El-laithy HM, Tadros MI.
    Int J Pharm; 2008 Jun 05; 357(1-2):189-98. PubMed ID: 18339494
    [Abstract] [Full Text] [Related]

  • 11. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, Woo JS, Yong CS.
    Int J Pharm; 2009 Jul 30; 377(1-2):1-8. PubMed ID: 19394413
    [Abstract] [Full Text] [Related]

  • 12. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S, Tian B, Chen F, Zhang W, Pan Y, Zhang Q, Yang X, Pan W.
    Drug Dev Ind Pharm; 2015 Jan 30; 41(1):51-62. PubMed ID: 24111828
    [Abstract] [Full Text] [Related]

  • 13. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP, Shenoy BD, Tiwari SB, Karki R, Udupa N, Kotian M.
    Indian J Exp Biol; 2000 Feb 30; 38(2):113-8. PubMed ID: 11218826
    [Abstract] [Full Text] [Related]

  • 14. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
    El-Laithy HM, Shoukry O, Mahran LG.
    Eur J Pharm Biopharm; 2011 Jan 30; 77(1):43-55. PubMed ID: 21056658
    [Abstract] [Full Text] [Related]

  • 15. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N, Khan AN.
    Drug Deliv; 2017 Jan 30; 24(sup1):56-69. PubMed ID: 29130758
    [Abstract] [Full Text] [Related]

  • 16. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A, Anwer MK, Talegaonkar S.
    J Drug Target; 2009 Nov 30; 17(9):671-89. PubMed ID: 19845484
    [Abstract] [Full Text] [Related]

  • 17. Proniosomes in transdermal drug delivery.
    Rahimpour Y, Kouhsoltani M, Hamishehkar H.
    Curr Pharm Des; 2015 Nov 30; 21(20):2883-91. PubMed ID: 25925111
    [Abstract] [Full Text] [Related]

  • 18. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S, Kushwaha S, Warsi MH, Anwar M, Ahmad MZ, Ahmad I, Talegaonkar S, Khan ZI, Khar RK, Ahmad FJ.
    Drug Dev Ind Pharm; 2012 Jan 30; 38(1):84-92. PubMed ID: 21726136
    [Abstract] [Full Text] [Related]

  • 19. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V, Praveen C, Prasanth KG, Srinivas CR, Ruckmann K.
    Pharmazie; 2009 Nov 30; 64(11):731-4. PubMed ID: 20099517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.